Myles Hume

Public MIGS funding a step closer for iTrack in Australia

Nova Eye Medical has announced an application to secure public funding for its iTrack ab-interno canaloplasty as a standalone minimally invasive glaucoma surgery (MIGS) procedure in Australia has formally progressing to the third and final stage of the assessment process. Read more

Anti-VEGF becomes most expensive drug on PBS

The Australian government spent more than $610 million on anti-VEGF treatments during the past year, with aflibercept (Eylea) leapfrogging a hepatitis C drug to become the costliest subsidised drug for the first time.   Read more

Taking independent optometry to the leading edge

George & Matilda Eyecare has rapidly grown its network to around 90 practices in four years. With plans to double in size by 2024, founder and managing director CHRIS BEER explains how data scientists, AI, and advanced digital assets are driving value to independent optometry.

Read more